Related Experiment Video
Updated: May 10, 2026

Whole-body PET/MRI of Pediatric Patients: The Details That Matter
Published on: December 19, 2017
Pediatric hepatobiliary magnetic resonance imaging
Vy Thao Tran1, Shreyas Vasanawala
1Department of Radiology, Lucile Packard Children's Hospital, Stanford University, 725 Welch Road Room 1667, Palo Alto, CA 94304, USA.
Magnetic resonance (MR) imaging offers a noninvasive method for diagnosing pediatric liver and biliary conditions. This review details MR protocols and common imaging features for various pediatric hepatobiliary diseases.
Area of Science:
- Radiology
- Pediatric Imaging
- Hepatobiliary Diseases
Background:
- Magnetic resonance (MR) imaging is a key noninvasive tool for assessing hepatobiliary pathology.
- Pediatric hepatobiliary imaging requires specific protocols and understanding of unique disease presentations.
Purpose of the Study:
- To provide an updated review of pediatric MR hepatobiliary imaging.
- To cover anatomy, indications, imaging protocols, and common pathologies.
Main Methods:
- Review of current literature and established guidelines for pediatric MR hepatobiliary imaging.
- Detailed description of patient preparation, pulse sequences, and contrast agents.
- Compilation of characteristic MR features for common pediatric liver conditions.
Main Results:
- MR imaging is highly effective for evaluating pediatric hepatobiliary conditions.
- Established protocols optimize image quality and diagnostic accuracy.
- Specific MR features aid in diagnosing tumors, malformations, trauma, fibrosis, and infections.
Conclusions:
- This review offers a comprehensive guide to pediatric MR hepatobiliary imaging.
- Understanding MR protocols and findings is crucial for diagnosing pediatric liver diseases.
- MR imaging plays a vital role in the noninvasive evaluation of pediatric hepatobiliary pathology.
Related Concept Videos
Magnetic Resonance Imaging
Imaging Studies IV: Magnetic Resonance Imaging
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

